VITASPRING BIOMEDICAL CO. LTD. (NASDAQ:VSBC) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on January 13, 2026.
The company reported Q0 revenue of $0.
VITASPRING BIOMEDICAL CO. LTD.'s stock currently trades at $0.00 with a market capitalization of $0.